Details of the Drug
General Information of Drug (ID: DMWEKBD)
Drug Name |
Phenyl-1,4-bismaleimide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3278-31-7; N,N'-1,4-Phenylenedimaleimide; N,N'-p-Phenylenedimaleimide; N,N'-4-Phenylenedimaleimide; phenyl-1,4-bismaleimide; UNII-BEC7P1E6J1; 1,1'-(1,4-phenylene)bis(1h-pyrrole-2,5-dione); BEC7P1E6J1; n,n-1,4-phenylenedimaleimide; CHEMBL576594; 1,1'-Benzene-1,4-diylbis(1H-pyrrole-2,5-dione); 1-[4-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione; NSC81257; EINECS 221-910-6; NSC 81257; p-PDM; 1,4-Dimaleimidobenzene; ACMC-209hvr; AC1Q6MZN; 1,4-phenylene dimaleimide; 1,4-bis(maleimido)benzene; AC1L2RM9; SCHEMBL95324
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 268.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||